← Eichor
Study identifier: NCT06253000 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Radiofrequency and Cryoablation of the Posterior Wall of the Left Atrium

Condition: Stroke · Acute Cerebrovascular Accident · Transient Ischemic Attack  ·  Sponsor: Bakulev Scientific Center of Cardiovascular Surgery

PhaseNA
Planned participants158
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Atrial fibrillation (AF) is the cause of 20% of strokes, and the risk of stroke in a person suffering from this arrhythmia increases by 5 times. Ischemic stroke in patients with AF is often fatal and, compared with stroke of other etiology, leads to the most pronounced disability and more often recurs. Accordingly, the risk of death in patients with AF-related stroke is 2 times higher, and treatment costs increase 1.5 times. The main interventional method of treating AF, available in most medical institutions, is the use of radio frequency and/or cryoenergy to eliminate destructive damage to the left atrium (LA). The aim of this study is to compare two different interventional methods and identify predictors of recurrence in patients with persistent and long-term AF.

This description comes directly from the study's public registry record.

Talk to the study team

Andrey Filatov  ·  +7(495) 414-77-02  ·  agfilatov@bakulev.ru

Always discuss trial participation with your own doctor first.

Locations (1)

Bakulev National Medical Research Center for Cardiovascular SurgeryMoscow, RussiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06253000